Sort
48,018 grants matching “immunotherapy”
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation
$524,944Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation
$524,944Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)
$524,929Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$524,804David B Shackelford · University Of California Los Angeles · R01 · FY2023 · CA
Identification of human tumor-associated antigens
$524,784Kwong Yok Tsang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Analyses of human T regulatory cells
$524,784Kwong Yok Tsang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Targeting HER2-low breast cancer with 17p loss
$524,740Xiongbin Lu · Indiana University Indianapolis · R01 · FY2023 · CA
Targeting HER2-low breast cancer with 17p loss
$524,740Xiongbin Lu · Indiana University Indianapolis · R01 · FY2022 · CA
Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer
$524,728Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$524,728Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation
$524,725Leonid Pobezinskiy · University Of Massachusetts Amherst · R01 · FY2024 · AI
Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-
$524,715Laurence J.n. Cooper · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy
$524,691Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2021 · NS
Investigational Cancer Therapeutics Training Program
$524,686Mark G Kris · Sloan-Kettering Inst Can Research · T32 · FY2015 · CA
Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal
$524,648Joseph A. Carcillo · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · GM
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL
$524,636Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
BRAIN TUMORS - IMMUNOLOGICAL AND BIOLOGICAL STUDIES
$524,623Duke University · R37 · FY2002 · CA
ANTIIDIOTYPE THERAPY OF HUMAN B CELL MALIGNANCY
$524,483Stanford University · R37 · FY2000 · CA
Immune Dysregulation by Human Papillomavirus during Head and Neck Cancer Progression
$524,441Dohun Pyeon · Michigan State University · R01 · FY2019 · DE
Molecular basis and targeting of FASN in expanding PARPi utility for TNBC
$524,419Jian-Ting Zhang · University Of Toledo Health Sci Campus · R01 · FY2025 · CA
Cell migration and cell-cell interactions in bone marrow
$524,412Ulrich H Von Andrian · Immune Disease Institute, Inc. · P01 · FY2010 · HL
Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy
$524,375Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2023 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$524,358James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Vaccine and radiation for the therapy of human cancers
$524,358James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Adaptive-Innate Immune Crosstalk in TGF-B Control of Peripheral T Cell Tolerance
$524,247Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2019 · AI